They found that knockdown of TRMT10A expression in U251 glioma cells resulted in upregulation of tRNA-Arg-CCT-derived tRF-22 (tRF-22-8XF6RE98N) along with decrease in m1G9 modification of tRNA-Arg-CCT. The gene discussed is TRMT10A; the disease is central nervous system cancer.